Case Study Undergraduate 466 words

Johnson & Johnson Tylenol Crisis: A PR Success Story

~3 min read

Abstract

This paper analyzes Johnson & Johnson's response to the 1982 Chicago Tylenol poisoning crisis, in which seven people died after an unknown suspect laced Extra-Strength Tylenol capsules with lethal doses of cyanide. The paper traces the company's immediate decision to prioritize consumer safety over profits, its nationwide product recall, and the six-week public relations campaign that re-introduced the product with triple-seal tamper-resistant packaging, consumer coupons, and discounted pricing. It concludes that the company's transparent, rapid response is widely regarded as one of the most effective crisis management efforts in public relations history, enabling Tylenol to recover seventy percent of its market share within five months.

📝 How to Write This Type of Paper Writing guide — click to expand

▼

What makes this paper effective

It presents a clear chronological narrative — from crisis onset to recovery — making the cause-and-effect relationship between corporate decisions and outcomes easy to follow.
It grounds its analysis in specific, concrete data points (market share percentages, timelines, and campaign components), lending credibility to its claims.
It balances description with evaluation, not only recounting what Johnson & Johnson did but explaining why those actions were effective from a public relations standpoint.

Key academic technique demonstrated

The paper uses a real-world case study as evidence for a broader claim — that transparent, consumer-first crisis communication is the most effective form of brand protection. Rather than arguing abstractly, it anchors every evaluative claim to a documented action or measurable outcome, a technique that makes argumentation both persuasive and verifiable.

Structure breakdown

The paper opens by establishing the severity of the crisis and its immediate market impact, then moves to Johnson & Johnson's ethical decision-making, followed by a bulleted breakdown of specific campaign tactics. It closes with an assessment of long-term outcomes and the case's standing in public relations literature. This intro–action–outcome structure is well-suited to case study writing at the undergraduate level.

Introduction: The 1982 Tylenol Poisoning Crisis

In October 1982, seven people in Chicago died after taking Extra-Strength Tylenol. The product had been tampered with after it reached store shelves by an unknown suspect who had laced the capsules with lethal doses of cyanide. Before the incident, Tylenol held a thirty-seven percent market share and generated revenue of approximately $1.2 million. Immediately following the poisonings, its market share fell to just seven percent, and some predicted the product would never recover. However, Johnson & Johnson initiated a successful public relations campaign that quickly restored the product's standing.

Johnson & Johnson's Immediate Response

Directly after discovering that the deaths in Chicago were caused by Extra-Strength Tylenol, Johnson & Johnson made the decision to place customer safety ahead of company profits (Kaplan). Rather than attempting to conceal the situation, the company immediately alerted consumers across the nation not to consume any type of Tylenol product. It warned consumers not to resume using the product until the extent of the tampering could be determined, halted all new production, and recalled all existing Tylenol capsules from the market.

2 Locked Sections · 205 words remaining

The Product Re-Introduction Campaign · 130 words

"Six-week campaign rebuilds consumer trust and sales"

Outcome and Legacy in Public Relations · 75 words

"Market share recovered; case becomes PR benchmark"

You’re 36% through this paper. Sign up to read the remaining 2 sections.

130,000+ paper examples AI writing assistant Citation generator Cancel anytime

Key Concepts in This Paper

Crisis Management Product Tampering Consumer Safety Brand Recovery Tamper-Resistant Packaging Market Share Public Relations Corporate Transparency FDA Compliance Tylenol Recall